Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(TSX:
SVA
)
0.1650
UNCHANGED
Streaming Delayed Price
Updated: 1:33 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,500
Open
0.1700
Bid (Size)
0.1600 (480)
Ask (Size)
0.1650 (5)
Prev. Close
0.1650
Today's Range
0.1650 - 0.1700
52wk Range
0.1500 - 0.3950
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
May 22, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
April 30, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
Performance
YTD
-28.3%
-28.3%
1 Month
-17.5%
-17.5%
3 Month
-15.4%
-15.4%
6 Month
-32.7%
-32.7%
1 Year
-57.1%
-57.1%
More News
Read More
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
April 29, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
Sernova Announces Key New Executive Appointments
October 11, 2024
Via
TheNewswire.com
Vivo Capital Files Lawsuits to Protect Sinovac Shareholders from the New Board’s Value Destructive Actions
April 23, 2025
From
Vivo Capital
Via
Business Wire
SINOVAC Announces Decision to Declare Cash Dividend
April 01, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Announces New Board Member and Chairman of the Audit Committee
March 28, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
February 28, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Issues Statement Regarding Privy Council Judgment
January 16, 2025
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 16, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
October 03, 2024
Via
NewMediaWire
SINOVAC Reports Unaudited First Half of 2024 Financial Results
August 16, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
April 29, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Sernova Provides Positive Clinical and Platform Portfolio Update
April 02, 2024
Via
TheNewswire.com
Sinovac Amends Shareholder Rights Plan
February 21, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
January 18, 2024
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
September 11, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
September 05, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
August 29, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Sinovac Announces Change of Legal Representative of Sinovac Beijing
August 28, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Reports Unaudited First Half of 2023 Financial Results
August 15, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
May 10, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
May 01, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
February 22, 2023
Via
Investor Brand Network
Sinovac Amends Shareholder Rights Plan
February 22, 2023
From
Sinovac Biotech Ltd.
Via
Business Wire
Frequently Asked Questions
Is SVA publicly traded?
Yes, SVA is publicly traded.
What exchange does SVA trade on?
SVA trades on the Toronto Stock Exchange
What is the ticker symbol for SVA?
The ticker symbol for SVA is SVA on the Toronto Stock Exchange
What is the current price of SVA?
The current price of SVA is 0.1650
When was SVA last traded?
The last trade of SVA was at 06/06/25 01:33 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.